Shandong Weigao Group Medical Polymer Co. Ltd. Class H 1066

HKEX · Hong Kong SAR China · Health Technology

HKD 3.33+0.08 (+2.46%)

Market closed· Sep 30, 2026, 8:08 AM UTC· HKD · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Shandong Weigao Group Medical Polymer Co. Ltd. Class H 1066

HKEX · Hong Kong SAR China · Health Technology

HKD 3.33+0.08 (+2.46%)

Market closed· Sep 30, 2026, 8:08 AM UTC· HKD · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

-11.90% · 6MFull-screen chart

Open HKD 3.28High HKD 3.33Low HKD 3.23Close HKD 3.33Volume 7.46M

Sep 30, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: HKD 3.25
Day range: HKD 3.23 – HKD 3.33
52-week range: HKD 2.92 – HKD 6.30
Volume: 7.46M
Market cap: HKD 15.06B
P/E (last fiscal year): 8.5
Dividend yield (annualized): 5.25%
Next earnings date: 2027-03-30
Avg. volume (1Y): 18.39M

Performance

1 week

+1.11%

1 month

-4.48%

3 months

-1.08%

6 months

-13.78%

Year to date

-35.46%

1 year

-41.00%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Medical Specialties
Country: Hong Kong SAR China
Exchange: HKEX
Shares outstanding: 4.46B
Employees: 13,307
ISIN: CNE100000171
Beta: 0.66

Technical view

Mixed

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceAug 25, 2026

Shandong Weigao Group Medical Polymer (SEHK:1066), What Is Behind The Latest Attention?

Half year earnings highlight mixed trends for Shandong Weigao Group Medical Polymer Shandong Weigao Group Medical Polymer (SEHK:1066) has released half year results to 30 June 2026, reporting sales of CNY 6,848.99 million and net income of CNY 774.12 million. For the same period in 2025, sales were CNY 6,644.05 million and net income was CNY 1,008.32 million. Basic and diluted earnings per share from continuing operations were CNY 0.17, compared with CNY 0.22 a year earlier. See our latest...

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.